FDA.reportPublic FDA data

paliperidone palmitate 1092 per 3.5 ML Prefilled Syringe

RxCUI
2570418
RxNorm name
paliperidone palmitate 1092 per 3.5 ML Prefilled Syringe
Display name
paliperidone palmitate 1092 per 3.5 ML Prefilled Syringe
Full name
paliperidone palmitate 1092 per 3.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INVEGA HAFYERAPALIPERIDONE PALMITATEJanssen Pharmaceuticals, Inc6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b2025-02-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2570418

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
6cd61892-d2cb-434d-83ed-5c1b2c4e7a0bpaliperidone palmitate 1092 per 3.5 ML Prefilled SyringeSY8These highlights do not include all the information needed to use INVEGA HAFYERA safely and effectively. See full prescribing information for INVEGA HAFYERA. INVEGA HAFYERA ® (paliperidone palmitate) extended-release injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 200620250218
6cd61892-d2cb-434d-83ed-5c1b2c4e7a0bpaliperidone palmitate 1092 in 3.5 ML Prefilled SyringePSN8These highlights do not include all the information needed to use INVEGA HAFYERA safely and effectively. See full prescribing information for INVEGA HAFYERA. INVEGA HAFYERA ® (paliperidone palmitate) extended-release injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 200620250218
6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b3.5 ML paliperidone palmitate 312 MG/ML Prefilled SyringeSCD8These highlights do not include all the information needed to use INVEGA HAFYERA safely and effectively. See full prescribing information for INVEGA HAFYERA. INVEGA HAFYERA ® (paliperidone palmitate) extended-release injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 200620250218